Catheter Precision investors to buy 2,050 Series C-4 preferred shares in USD 2.05 million private placement

• Catheter Precision priced a $2.05 million private placement of 2,050 shares of Series C-4 Convertible Preferred Stock.
• Closing expected on or about Oct. 13, 2026, subject to customary closing conditions.
• Preferred stock converts at $1.00 per share into up to 2,050,000 common shares, subject to a 4.99% beneficial ownership cap.
• Transaction relied on Section 4(a)(2) and Rule 506(b) exemptions; securities remain unregistered, restricted under Rule 144.
• Conversion price for outstanding Series C-1 through C-4, Series D, and Series J preferred stock cut to $1.00 from $2.30.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Catheter Precision Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001437749-26-032456), on October 09, 2026, and is solely responsible for the information contained therein.